Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated ...

Did you miss important UPSC current affairs from the past week? Here are the must-know topics you should catch up on: Pax ...